TP-MV: Therapeutic protein prediction by multi-view learning

UniAMP: enhancing AMP prediction using deep neural networks with inferred information of peptides

Antimicrobial peptides (AMPs) have been widely recognized as a promising solution to combat antimicrobial resistance of microorganisms due to the increasing abuse of antibiotics in medicine and agriculture around the globe. In this study, we propose UniAMP, a systematic prediction framework for discovering AMPs. We observe that feature vectors used in various existing studies constructed from peptide information, such as sequence, composition, and structure, can be augmented and even replaced by information inferred by deep learning models. Specifically, we use a feature vector with 2924 values inferred by two deep learning models, UniRep and ProtT5, to demonstrate that such inferred information of peptides suffice for the task, with the help of our proposed deep neural network model composed of fully connected layers and transformer encoders for predicting the antibacterial activity of peptides. Evaluation results demonstrate superior performance of our proposed model on both balanced benchmark datasets and imbalanced test datasets compared with existing studies. Subsequently, we analyze the relations among peptide sequences, manually extracted features, and automatically inferred information by deep learning models, leading to observations that the inferred information is more comprehensive and non-redundant for the task of predicting AMPs. Moreover, this approach alleviates the impact of the scarcity of positive data and demonstrates great potential in future research and applications.

Exploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides

Cell-penetrating peptides (CPPs) are a diverse group of peptides, typically composed of 4 to 40 amino acids, known for their unique ability to transport a wide range of substances-such as small molecules, plasmid DNA, small interfering RNA, proteins, viruses, and nanoparticles-across cellular membranes while preserving the integrity of the cargo. CPPs exhibit passive and non-selective behavior, often requiring functionalization or chemical modification to enhance their specificity and efficacy. The precise mechanisms governing the cellular uptake of CPPs remain ambiguous; however, electrostatic interactions between positively charged amino acids and negatively charged glycosaminoglycans on the membrane, particularly heparan sulfate proteoglycans, are considered the initial crucial step for CPP uptake. Clinical trials have highlighted the potential of CPPs in diagnosing and treating various diseases, including cancer, central nervous system disorders, eye disorders, and diabetes. This review provides a comprehensive overview of CPP classifications, potential applications, transduction mechanisms, and the most relevant algorithms to improve the accuracy and reliability of predictions in CPP development.

ACP-GBDT: An improved anticancer peptide identification method with gradient boosting decision tree

Cancer is one of the most dangerous diseases in the world, killing millions of people every year. Drugs composed of anticancer peptides have been used to treat cancer with low side effects in recent years. Therefore, identifying anticancer peptides has become a focus of research. In this study, an improved anticancer peptide predictor named ACP-GBDT, based on gradient boosting decision tree (GBDT) and sequence information, is proposed. To encode the peptide sequences included in the anticancer peptide dataset, ACP-GBDT uses a merged-feature composed of AAIndex and SVMProt-188D. A GBDT is adopted to train the prediction model in ACP-GBDT. Independent testing and ten-fold cross-validation show that ACP-GBDT can effectively distinguish anticancer peptides from non-anticancer ones. The comparison results of the benchmark dataset show that ACP-GBDT is simpler and more effective than other existing anticancer peptide prediction methods.

PreTP-Stack: Prediction of Therapeutic Peptides Based on the Stacked Ensemble Learing

Therapeutic peptide prediction is critical for drug development and therapeutic therapy. Researchers have developed several computational methods to identify different therapeutic peptide types. However, most computational methods focus on identifying the specific type of therapeutic peptides and fail to accurately predict all types of therapeutic peptides. Moreover, it is still challenging to utilize different properties features to predict the therapeutic peptides. In this study, a novel stacking framework PreTP-Stack is proposed for predicting different types of therapeutic peptide. PreTP-Stack is constructed based on ten different features and four predictors (Random Forest, Linear Discriminant Analysis, XGBoost and Support Vector Machine). Then the proposed method constructs an auto-weighted multi-view learning model as a final meta-classifier to enhance the performance of the basic models. Experimental results showed that the proposed method achieved better or highly comparable performance with the state-of-the-art methods for predicting eight types of therapeutic peptides A user-friendly web-server predictor is available at http://bliulab.net/PreTP-Stack.

sAMPpred-GAT: prediction of antimicrobial peptide by graph attention network and predicted peptide structure

MOTIVATION

Antimicrobial peptides (AMPs) are essential components of therapeutic peptides for innate immunity. Researchers have developed several computational methods to predict the potential AMPs from many candidate peptides. With the development of artificial intelligent techniques, the protein structures can be accurately predicted, which are useful for protein sequence and function analysis. Unfortunately, the predicted peptide structure information has not been applied to the field of AMP prediction so as to improve the predictive performance.

RESULTS

In this study, we proposed a computational predictor called sAMPpred-GAT for AMP identification. To the best of our knowledge, sAMPpred-GAT is the first approach based on the predicted peptide structures for AMP prediction. The sAMPpred-GAT predictor constructs the graphs based on the predicted peptide structures, sequence information and evolutionary information. The Graph Attention Network (GAT) is then performed on the graphs to learn the discriminative features. Finally, the full connection networks are utilized as the output module to predict whether the peptides are AMP or not. Experimental results show that sAMPpred-GAT outperforms the other state-of-the-art methods in terms of AUC, and achieves better or highly comparable performance in terms of the other metrics on the eight independent test datasets, demonstrating that the predicted peptide structure information is important for AMP prediction.

AVAILABILITY AND IMPLEMENTATION

A user-friendly webserver of sAMPpred-GAT can be accessed at http://bliulab.net/sAMPpred-GAT and the source code is available at https://github.com/HongWuL/sAMPpred-GAT/.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

PrMFTP: Multi-functional therapeutic peptides prediction based on multi-head self-attention mechanism and class weight optimization

Prediction of therapeutic peptide is a significant step for the discovery of promising therapeutic drugs. Most of the existing studies have focused on the mono-functional therapeutic peptide prediction. However, the number of multi-functional therapeutic peptides (MFTP) is growing rapidly, which requires new computational schemes to be proposed to facilitate MFTP discovery. In this study, based on multi-head self-attention mechanism and class weight optimization algorithm, we propose a novel model called PrMFTP for MFTP prediction. PrMFTP exploits multi-scale convolutional neural network, bi-directional long short-term memory, and multi-head self-attention mechanisms to fully extract and learn informative features of peptide sequence to predict MFTP. In addition, we design a class weight optimization scheme to address the problem of label imbalanced data. Comprehensive evaluation demonstrate that PrMFTP is superior to other state-of-the-art computational methods for predicting MFTP. We provide a user-friendly web server of PrMFTP, which is available at http://bioinfo.ahu.edu.cn/PrMFTP.

iDRNA-ITF: identifying DNA- and RNA-binding residues in proteins based on induction and transfer framework

Protein-DNA and protein-RNA interactions are involved in many biological activities. In the post-genome era, accurate identification of DNA- and RNA-binding residues in protein sequences is of great significance for studying protein functions and promoting new drug design and development. Therefore, some sequence-based computational methods have been proposed for identifying DNA- and RNA-binding residues. However, they failed to fully utilize the functional properties of residues, leading to limited prediction performance. In this paper, a sequence-based method iDRNA-ITF was proposed to incorporate the functional properties in residue representation by using an induction and transfer framework. The properties of nucleic acid-binding residues were induced by the nucleic acid-binding residue feature extraction network, and then transferred into the feature integration modules of the DNA-binding residue prediction network and the RNA-binding residue prediction network for the final prediction. Experimental results on four test sets demonstrate that iDRNA-ITF achieves the state-of-the-art performance, outperforming the other existing sequence-based methods. The webserver of iDRNA-ITF is freely available at http://bliulab.net/iDRNA-ITF.

TPpred-ATMV: therapeutic peptide prediction by adaptive multi-view tensor learning model

MOTIVATION

Therapeutic peptide prediction is important for the discovery of efficient therapeutic peptides and drug development. Researchers have developed several computational methods to identify different therapeutic peptide types. However, these computational methods focus on identifying some specific types of therapeutic peptides, failing to predict the comprehensive types of therapeutic peptides. Moreover, it is still challenging to utilize different properties to predict the therapeutic peptides.

RESULTS

In this study, an adaptive multi-view based on the tensor learning framework TPpred-ATMV is proposed for predicting different types of therapeutic peptides. TPpred-ATMV constructs the class and probability information based on various sequence features. We constructed the latent subspace among the multi-view features and constructed an auto-weighted multi-view tensor learning model to utilize the high correlation based on the multi-view features. Experimental results showed that the TPpred-ATMV is better than or highly comparable with the other state-of-the-art methods for predicting eight types of therapeutic peptides.

AVAILABILITY AND IMPLEMENTATION

The code of TPpred-ATMV is accessed at: https://github.com/cokeyk/TPpred-ATMV.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

iLncDA-LTR: Identification of lncRNA-disease associations by learning to rank

Identifying the associations between lncRNAs and diseases is helpful for the treatment and diagnosis of complex diseases. The existing computational methods mainly focus on the identification of associations between known lncRNAs and known diseases. However, with the application of high-throughput sequencing in lncRNA research, more and more lncRNAs have been detected. Predicting diseases related with newly detected lncRNAs has not been fully explored. Therefore, there is an urgent need for developing powerful computational methods to predict diseases related with newly detected lncRNAs. In this paper, we propose a Learning to Rank (LTR)-based method called iLncDA-LTR to predict diseases related with newly detected lncRNAs. iLncDA-LTR treats this task as an information retrieval task. The newly detected lncRNAs and diseases are considered as queries and documents, respectively. For a given newly detected lncRNA (query), iLncDA-LTR integrates multiple relevant information into LTR for predicting candidate diseases associated with query lncRNA. Experimental results show that iLncDA-LTR outperforms the other exiting state-of-the-art predictors on independent dataset. The corresponding web server of iLncDA-LTR has been constructed as well (http://bliulab.net/iLncDA-LTR/).

AMPpred-EL: An effective antimicrobial peptide prediction model based on ensemble learning

Antimicrobial peptides (AMPs) are important for the human immune system and are currently applied in clinical trials. AMPs have been received much attention for accurate recognition. Recently, several computational methods for identifying AMPs have been proposed. However, existing methods have difficulty in accurately predicting AMPs. In this paper, we propose a novel AMP prediction method called AMPpred-EL based on an ensemble learning strategy. AMPred-EL is constructed based on ensemble learning combined with LightGBM and logistic regression. Experimental results demonstrate that AMPpred-EL outperforms several state-of-the-art methods on the benchmark datasets and then improves the efficiency performance.